P407: MITOTIC FIDELITY IS A RESISTANCE MECHANISM TO DECITABINE IN MYELOID TUMORS.

• Tomohiro Yabushita,
• Takumi Chinen,
• Atsuya Nishiyama,
• Shuhei Asada,
• Keita Yamamoto,
• Naru Sato,
• Yutaka Enomoto,
• Keiko Katoh,
• Kaori Saitoh,
• Takamasa Ishikawa,
• Tomoyoshi Soga,
• Yasuhito Nannya,
• Makoto Nakanishi,
• Daiju Kitagawa,
• Toshio Kitamura,
• Susumu Goyama

Affiliations

Tomohiro Yabushita

1 The University of Tokyo, Molecular Pharmacology of Malignant Diseases, Graduate School of Pharmaceutical Sciences, Bunkyo City, Japan

Takumi Chinen

2 The University of Tokyo, Bunkyo City, Japan

Atsuya Nishiyama

3 The Institute of Medical Science, The University of Tokyo, Minato City, Japan

Shuhei Asada

3 The Institute of Medical Science, The University of Tokyo, Minato City, Japan

Keita Yamamoto

4 The University of Tokyo, Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, Japan

Naru Sato

1 The University of Tokyo, Molecular Pharmacology of Malignant Diseases, Graduate School of Pharmaceutical Sciences, Bunkyo City, Japan

Yutaka Enomoto

1 The University of Tokyo, Molecular Pharmacology of Malignant Diseases, Graduate School of Pharmaceutical Sciences, Bunkyo City, Japan

Keiko Katoh

5 Institute for Advanced Biosciences (IAB), Tsuruoka, Japan

Kaori Saitoh

5 Institute for Advanced Biosciences (IAB), Tsuruoka, Japan

Takamasa Ishikawa

5 Institute for Advanced Biosciences (IAB), Tsuruoka, Japan

Tomoyoshi Soga

5 Institute for Advanced Biosciences (IAB), Tsuruoka, Japan

Yasuhito Nannya

6 Institute of Medical Science, University of Tokyo, Minato City, Japan

Makoto Nakanishi

3 The Institute of Medical Science, The University of Tokyo, Minato City, Japan

Daiju Kitagawa

2 The University of Tokyo, Bunkyo City, Japan

Toshio Kitamura

1 The University of Tokyo, Molecular Pharmacology of Malignant Diseases, Graduate School of Pharmaceutical Sciences, Bunkyo City, Japan

Susumu Goyama

7 The University of Tokyo, Japan, Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences,